Quantitative analysis of the relative mutagenicity of five chemical constituents of tobacco smoke in the mouse lymphoma assay

Quantifying health-related biological effects, like genotoxicity, could provide a way of distinguishing between tobacco products. In order to develop tools for using genotoxicty data to quantitatively evaluate the risk of tobacco products, we tested five carcinogens found in cigarette smoke, 4-amino...

Full description

Saved in:
Bibliographic Details
Published inMutagenesis Vol. 31; no. 3; pp. 287 - 296
Main Authors Guo, Xiaoqing, Heflich, Robert H., Dial, Stacey L., Richter, Patricia A., Moore, Martha M., Mei, Nan
Format Journal Article
LanguageEnglish
Published England 01.05.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Quantifying health-related biological effects, like genotoxicity, could provide a way of distinguishing between tobacco products. In order to develop tools for using genotoxicty data to quantitatively evaluate the risk of tobacco products, we tested five carcinogens found in cigarette smoke, 4-aminobiphenyl (4-ABP), benzo[a]pyrene (BaP), cadmium (in the form of CdCl2), 2-amino-3,4-dimethyl-3H-imidazo[4,5-f]quinoline (MeIQ) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the mouse lymphoma assay (MLA). The resulting mutagenicity dose responses were analyzed by various quantitative approaches and their strengths and weaknesses for distinguishing responses in the MLA were evaluated. L5178Y/Tk (+/-) 3.7.2C mouse lymphoma cells were treated with four to seven concentrations of each chemical for 4h. Only CdCl2 produced a positive response without metabolic activation (S9); all five chemicals produced dose-dependent increases in cytotoxicity and mutagenicity with S9. The lowest dose exceeding the global evaluation factor, the benchmark dose producing a 10%, 50%, 100% or 200% increase in the background frequency (BMD10, BMD50, BMD100 and BMD200), the no observed genotoxic effect level (NOGEL), the lowest observed genotoxic effect level (LOGEL) and the mutagenic potency expressed as a mutant frequency per micromole of chemical, were calculated for all the positive responses. All the quantitative metrics had similar rank orders for the agents' ability to induce mutation, from the most to least potent as CdCl2(-S9) > BaP(+S9) > CdCl2(+S9) > MeIQ(+S9) > 4-ABP(+S9) > NNK(+S9). However, the metric values for the different chemical responses (i.e. the ratio of the greatest value to the least value) for the different chemicals ranged from 16-fold (BMD10) to 572-fold (mutagenic potency). These results suggest that data from the MLA are capable of discriminating the mutagenicity of various constituents of cigarette smoke, and that quantitative analyses are available that can be useful in distinguishing between the exposure responses.
AbstractList Quantifying health-related biological effects, like genotoxicity, could provide a way of distinguishing between tobacco products. In order to develop tools for using genotoxicty data to quantitatively evaluate the risk of tobacco products, we tested five carcinogens found in cigarette smoke, 4-aminobiphenyl (4-ABP), benzo[a]pyrene (BaP), cadmium (in the form of CdCl2), 2-amino-3,4-dimethyl-3H-imidazo[4,5-f]quinoline (MeIQ) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the mouse lymphoma assay (MLA). The resulting mutagenicity dose responses were analyzed by various quantitative approaches and their strengths and weaknesses for distinguishing responses in the MLA were evaluated. L5178Y/Tk (+/-) 3.7.2C mouse lymphoma cells were treated with four to seven concentrations of each chemical for 4h. Only CdCl2 produced a positive response without metabolic activation (S9); all five chemicals produced dose-dependent increases in cytotoxicity and mutagenicity with S9. The lowest dose exceeding the global evaluation factor, the benchmark dose producing a 10%, 50%, 100% or 200% increase in the background frequency (BMD10, BMD50, BMD100 and BMD200), the no observed genotoxic effect level (NOGEL), the lowest observed genotoxic effect level (LOGEL) and the mutagenic potency expressed as a mutant frequency per micromole of chemical, were calculated for all the positive responses. All the quantitative metrics had similar rank orders for the agents' ability to induce mutation, from the most to least potent as CdCl2(-S9) > BaP(+S9) > CdCl2(+S9) > MeIQ(+S9) > 4-ABP(+S9) > NNK(+S9). However, the metric values for the different chemical responses (i.e. the ratio of the greatest value to the least value) for the different chemicals ranged from 16-fold (BMD10) to 572-fold (mutagenic potency). These results suggest that data from the MLA are capable of discriminating the mutagenicity of various constituents of cigarette smoke, and that quantitative analyses are available that can be useful in distinguishing between the exposure responses.Quantifying health-related biological effects, like genotoxicity, could provide a way of distinguishing between tobacco products. In order to develop tools for using genotoxicty data to quantitatively evaluate the risk of tobacco products, we tested five carcinogens found in cigarette smoke, 4-aminobiphenyl (4-ABP), benzo[a]pyrene (BaP), cadmium (in the form of CdCl2), 2-amino-3,4-dimethyl-3H-imidazo[4,5-f]quinoline (MeIQ) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the mouse lymphoma assay (MLA). The resulting mutagenicity dose responses were analyzed by various quantitative approaches and their strengths and weaknesses for distinguishing responses in the MLA were evaluated. L5178Y/Tk (+/-) 3.7.2C mouse lymphoma cells were treated with four to seven concentrations of each chemical for 4h. Only CdCl2 produced a positive response without metabolic activation (S9); all five chemicals produced dose-dependent increases in cytotoxicity and mutagenicity with S9. The lowest dose exceeding the global evaluation factor, the benchmark dose producing a 10%, 50%, 100% or 200% increase in the background frequency (BMD10, BMD50, BMD100 and BMD200), the no observed genotoxic effect level (NOGEL), the lowest observed genotoxic effect level (LOGEL) and the mutagenic potency expressed as a mutant frequency per micromole of chemical, were calculated for all the positive responses. All the quantitative metrics had similar rank orders for the agents' ability to induce mutation, from the most to least potent as CdCl2(-S9) > BaP(+S9) > CdCl2(+S9) > MeIQ(+S9) > 4-ABP(+S9) > NNK(+S9). However, the metric values for the different chemical responses (i.e. the ratio of the greatest value to the least value) for the different chemicals ranged from 16-fold (BMD10) to 572-fold (mutagenic potency). These results suggest that data from the MLA are capable of discriminating the mutagenicity of various constituents of cigarette smoke, and that quantitative analyses are available that can be useful in distinguishing between the exposure responses.
Quantifying health-related biological effects, like genotoxicity, could provide a way of distinguishing between tobacco products. In order to develop tools for using genotoxicty data to quantitatively evaluate the risk of tobacco products, we tested five carcinogens found in cigarette smoke, 4-aminobiphenyl (4- ABP), benzo[ a ]pyrene (BaP), cadmium (in the form of CdCl 2 ), 2-amino-3,4-dimethyl-3H-imidazo[4,5-f] quinoline (MelQ) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the mouse lymphoma assay (MLA). The resulting mutagenicity dose responses were analyzed by various quantitative approaches and their strengths and weaknesses for distinguishing responses in the MLA were evaluated. L5178Y/ Tk +/− 3.7.2C mouse lymphoma cells were treated with four to seven concentrations of each chemical for 4 h. Only CdCl 2 produced a positive response without metabolic activation (S9); all five chemicals produced dose-dependent increases in cytotoxicity and mutagenicity with S9. The lowest dose exceeding the global evaluation factor, the benchmark dose producing a 10%, 50%, 100% or 200% increase in the background frequency (BMD 10 , BMD 50 , BMD 100 and BMD 200 ), the no observed genotoxic effect level (NOGEL), the lowest observed genotoxic effect level (LOGEL) and the mutagenic potency expressed as a mutant frequency per micromole of chemical, were calculated for all the positive responses. All the quantitative metrics had similar rank orders for the agents’ ability to induce mutation, from the most to least potent as CdCl 2 (-S9) > BaP(+S9) > CdCl 2 (+S9) > MeIQ(+S9) > 4-ABP(+S9) > NNK(+S9). However, the metric values for the different chemical responses (i.e. the ratio of the greatest value to the least value) for the different chemicals ranged from 16-fold (BMD 10 ) to 572-fold (mutagenic potency). These results suggest that data from the MLA are capable of discriminating the mutagenicity of various constituents of cigarette smoke, and that quantitative analyses are available that can be useful in distinguishing between the exposure responses.
Quantifying health-related biological effects, like genotoxicity, could provide a way of distinguishing between tobacco products. In order to develop tools for using genotoxicty data to quantitatively evaluate the risk of tobacco products, we tested five carcinogens found in cigarette smoke, 4-aminobiphenyl (4-ABP), benzo[a]pyrene (BaP), cadmium (in the form of CdCl2), 2-amino-3,4-dimethyl-3H-imidazo[4,5-f]quinoline (MeIQ) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the mouse lymphoma assay (MLA). The resulting mutagenicity dose responses were analyzed by various quantitative approaches and their strengths and weaknesses for distinguishing responses in the MLA were evaluated. L5178Y/Tk (+/-) 3.7.2C mouse lymphoma cells were treated with four to seven concentrations of each chemical for 4h. Only CdCl2 produced a positive response without metabolic activation (S9); all five chemicals produced dose-dependent increases in cytotoxicity and mutagenicity with S9. The lowest dose exceeding the global evaluation factor, the benchmark dose producing a 10%, 50%, 100% or 200% increase in the background frequency (BMD10, BMD50, BMD100 and BMD200), the no observed genotoxic effect level (NOGEL), the lowest observed genotoxic effect level (LOGEL) and the mutagenic potency expressed as a mutant frequency per micromole of chemical, were calculated for all the positive responses. All the quantitative metrics had similar rank orders for the agents' ability to induce mutation, from the most to least potent as CdCl2(-S9) > BaP(+S9) > CdCl2(+S9) > MeIQ(+S9) > 4-ABP(+S9) > NNK(+S9). However, the metric values for the different chemical responses (i.e. the ratio of the greatest value to the least value) for the different chemicals ranged from 16-fold (BMD10) to 572-fold (mutagenic potency). These results suggest that data from the MLA are capable of discriminating the mutagenicity of various constituents of cigarette smoke, and that quantitative analyses are available that can be useful in distinguishing between the exposure responses.
Quantifying health-related biological effects, like genotoxicity, could provide a way of distinguishing between tobacco products. In order to develop tools for using genotoxicty data to quantitatively evaluate the risk of tobacco products, we tested five carcinogens found in cigarette smoke, 4-aminobiphenyl (4-ABP), benzo[a]pyrene (BaP), cadmium (in the form of CdCl sub(2)), 2-amino-3,4-dimethyl-3H-imidazo[4,5-f]quinoline (MeIQ) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the mouse lymphoma assay (MLA). The resulting mutagenicity dose responses were analyzed by various quantitative approaches and their strengths and weaknesses for distinguishing responses in the MLA were evaluated. L5178Y/Tk super(+/-) 3.7.2C mouse lymphoma cells were treated with four to seven concentrations of each chemical for 4h. Only CdCl sub(2) produced a positive response without metabolic activation (S9); all five chemicals produced dose-dependent increases in cytotoxicity and mutagenicity with S9. The lowest dose exceeding the global evaluation factor, the benchmark dose producing a 10%, 50%, 100% or 200% increase in the background frequency (BMD sub(10), BMD sub(50), BMD sub(100) and BMD sub(200)), the no observed genotoxic effect level (NOGEL), the lowest observed genotoxic effect level (LOGEL) and the mutagenic potency expressed as a mutant frequency per micromole of chemical, were calculated for all the positive responses. All the quantitative metrics had similar rank orders for the agents' ability to induce mutation, from the most to least potent as CdCl sub(2)(-S9) > BaP(+S9) > CdCl sub(2)(+S9) > MeIQ(+S9) > 4-ABP(+S9) > NNK(+S9). However, the metric values for the different chemical responses (i.e. the ratio of the greatest value to the least value) for the different chemicals ranged from 16-fold (BMD sub(10)) to 572-fold (mutagenic potency). These results suggest that data from the MLA are capable of discriminating the mutagenicity of various constituents of cigarette smoke, and that quantitative analyses are available that can be useful in distinguishing between the exposure responses.
Author Dial, Stacey L.
Richter, Patricia A.
Moore, Martha M.
Heflich, Robert H.
Guo, Xiaoqing
Mei, Nan
AuthorAffiliation 2 Center for Tobacco Products, Silver Spring, MD 20993, USA
3 Present address: Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA 30341, USA
1 Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA
4 Ramboll Environ, 124 West Capitol Avenue, Suite 1890, Little Rock, AR 72201, USA
AuthorAffiliation_xml – name: 4 Ramboll Environ, 124 West Capitol Avenue, Suite 1890, Little Rock, AR 72201, USA
– name: 2 Center for Tobacco Products, Silver Spring, MD 20993, USA
– name: 1 Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA
– name: 3 Present address: Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA 30341, USA
Author_xml – sequence: 1
  givenname: Xiaoqing
  surname: Guo
  fullname: Guo, Xiaoqing
– sequence: 2
  givenname: Robert H.
  surname: Heflich
  fullname: Heflich, Robert H.
– sequence: 3
  givenname: Stacey L.
  surname: Dial
  fullname: Dial, Stacey L.
– sequence: 4
  givenname: Patricia A.
  surname: Richter
  fullname: Richter, Patricia A.
– sequence: 5
  givenname: Martha M.
  surname: Moore
  fullname: Moore, Martha M.
– sequence: 6
  givenname: Nan
  surname: Mei
  fullname: Mei, Nan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26001754$$D View this record in MEDLINE/PubMed
BookMark eNqFUk2LFDEQDbLizo4evUofvfRuvvrrIsiyusKCCHoO1enqmWg-xk56oA_-dzPbu6IieKmEvFevXnh1Qc588EjIS0YvGe3ElZsT7PBqh0cquidkw2QtS9FSeUY2lNdN2YqqOScXMX6llDW8ps_Iea75XskN-fFpBp9MgmSOWIAHu0QTizAWaY_FhHYF1ineaJOWEzieHvUendFgCx18zBoz-rS2hh60DkV04RsWxt9ruTBHLOziDvvgoIAYYXlOno5gI754OLfky7ubz9e35d3H9x-u396VWrZ1KmuAfuB0qPuBctSCcoBBS2Qj77nAirNO1NCMOpdq7OQgWEs70JS1fT_iILbkzap7mHuHg85GJ7DqMBkH06ICGPUn4s1e7cJR1ZJ1jPIs8PpBYArfZ4xJORM1Wgse879UnlfJTjDe_J_atKJjgufwtuTV77Z--XmMJxPEStBTiHHCUen7qMLJpbGKUXVaArXGo9YlyF3lX12Pwv_m_wTWHbt_
CitedBy_id crossref_primary_10_1007_s00204_019_02406_9
crossref_primary_10_1016_j_mrgentox_2019_04_002
crossref_primary_10_1016_j_taap_2023_116637
crossref_primary_10_1093_mutage_gew011
crossref_primary_10_1016_j_fct_2018_05_058
crossref_primary_10_1007_s00204_020_02736_z
crossref_primary_10_1093_toxsci_kfy022
crossref_primary_10_1016_j_mrgentox_2021_503351
crossref_primary_10_1007_s10653_016_9893_2
crossref_primary_10_1016_j_lungcan_2017_07_035
crossref_primary_10_1089_aivt_2020_0004
crossref_primary_10_1016_j_envint_2019_104943
crossref_primary_10_1016_j_mrgentox_2018_10_007
crossref_primary_10_1093_mutage_geaa032
crossref_primary_10_1093_mutage_geab021
crossref_primary_10_5487_TR_2018_34_4_303
crossref_primary_10_1016_j_tox_2021_152936
crossref_primary_10_1016_j_yrtph_2024_105709
crossref_primary_10_1007_s00204_018_2318_5
crossref_primary_10_1080_26896583_2024_2331956
crossref_primary_10_1002_em_22151
crossref_primary_10_1016_j_mrgentox_2022_503502
Cites_doi 10.1093/toxsci/kfs012
10.1093/toxsci/kfp037
10.3109/10408444.2013.853726
10.1016/j.fct.2003.08.020
10.1016/j.mrgentox.2014.10.008
10.1093/toxsci/kfn083
10.1016/j.mrrev.2004.02.001
10.1002/em.20159
10.1007/978-1-62703-742-6_34
10.1021/jf070649o
10.1093/carcin/bgn002
10.1021/tx0600907
10.1016/S0278-6915(00)00164-2
10.1038/nrc1190
10.1002/em.21870
10.1016/S0278-6915(97)00063-X
10.1016/j.yrtph.2005.07.003
10.1016/j.mrgentox.2009.12.011
10.1093/mutage/geq083
10.1002/em.21825
10.1016/j.taap.2010.10.016
10.1002/em.21698
10.1002/em.21854
10.1016/S0090-9556(24)15126-4
10.1016/j.tox.2006.07.019
10.1073/pnas.87.1.51
10.1002/em.21727
10.1371/journal.pone.0064532
10.1136/tc.2008.024778
10.1016/j.tox.2003.08.006
10.1016/j.mrgentox.2007.09.006
10.1016/j.mrgentox.2014.09.011
10.1038/nrc1546
10.1016/j.taap.2009.03.026
ContentType Journal Article
Copyright Published by Oxford University Press on behalf of the UK Environmental Mutagen Society 2015.
Copyright_xml – notice: Published by Oxford University Press on behalf of the UK Environmental Mutagen Society 2015.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7U7
C1K
5PM
DOI 10.1093/mutage/gev039
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Toxicology Abstracts
Environmental Sciences and Pollution Management
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE - Academic

MEDLINE
Toxicology Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1464-3804
EndPage 296
ExternalDocumentID PMC6419102
26001754
10_1093_mutage_gev039
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
Comparative Study
GrantInformation_xml – fundername: Intramural FDA HHS
  grantid: FD999999
GroupedDBID ---
-E4
.2P
.GJ
.I3
.ZR
0R~
123
18M
1TH
29M
2WC
4.4
482
48X
53G
5RE
5VS
5WA
5WD
70D
A8Z
AABZA
AACZT
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
AAWDT
AAYXX
ABDFA
ABEFU
ABEJV
ABEUO
ABGNP
ABIME
ABIXL
ABJNI
ABKDP
ABMNT
ABNGD
ABNHQ
ABNKS
ABPIB
ABPQP
ABPTD
ABQLI
ABSMQ
ABVGC
ABWST
ABXVV
ABXZS
ABZBJ
ABZEO
ACFRR
ACGFO
ACGFS
ACPQN
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACVCV
ACZBC
ADBBV
ADEYI
ADEZT
ADFTL
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZTZ
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKPW
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFQV
AFFZL
AFGWE
AFIYH
AFOFC
AFRAH
AFSHK
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGORE
AGQPQ
AGQXC
AGSYK
AHGBF
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJDVS
AJEEA
AJNCP
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
ANFBD
APIBT
APJGH
APWMN
AQDSO
AQKUS
ARIXL
ASAOO
ASPBG
ATDFG
ATGXG
ATTQO
AVNTJ
AVWKF
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSWAC
BTRTY
BVRKM
BZKNY
CAG
CDBKE
CITATION
COF
CS3
CXTWN
CZ4
DAKXR
DFGAJ
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EDH
EE~
EIHJH
EJD
ELUNK
EMOBN
F5P
F9B
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
H5~
HAR
HVGLF
HW0
HZ~
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
M-Z
MBLQV
MBTAY
N9A
NGC
NLBLG
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAWHX
OBFPC
OBOKY
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
SV3
TCN
TEORI
TJX
TLC
TMA
TR2
W8F
X7H
YAYTL
YKOAZ
YXANX
ZKX
ZXP
~91
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7U7
C1K
5PM
ID FETCH-LOGICAL-c486t-6aabd20d6bd02ec302aadc4e1f2b23e521936a7fc6a75f94d31809ac018bbfed3
ISSN 0267-8357
1464-3804
IngestDate Thu Aug 21 18:27:08 EDT 2025
Fri Jul 11 16:41:49 EDT 2025
Fri Jul 11 10:21:20 EDT 2025
Mon Jul 21 05:57:32 EDT 2025
Sun Jul 06 05:05:53 EDT 2025
Thu Apr 24 22:52:28 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Published by Oxford University Press on behalf of the UK Environmental Mutagen Society 2015.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c486t-6aabd20d6bd02ec302aadc4e1f2b23e521936a7fc6a75f94d31809ac018bbfed3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://academic.oup.com/mutage/article-pdf/31/3/287/8178342/gev039.pdf
PMID 26001754
PQID 1783913209
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6419102
proquest_miscellaneous_1805493127
proquest_miscellaneous_1783913209
pubmed_primary_26001754
crossref_citationtrail_10_1093_mutage_gev039
crossref_primary_10_1093_mutage_gev039
PublicationCentury 2000
PublicationDate 2016-05-01
PublicationDateYYYYMMDD 2016-05-01
PublicationDate_xml – month: 05
  year: 2016
  text: 2016-05-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Mutagenesis
PublicationTitleAlternate Mutagenesis
PublicationYear 2016
References 2016042200275824000_31.3.287.17
2016042200275824000_31.3.287.39
2016042200275824000_31.3.287.18
2016042200275824000_31.3.287.15
2016042200275824000_31.3.287.37
2016042200275824000_31.3.287.16
2016042200275824000_31.3.287.38
2016042200275824000_31.3.287.13
2016042200275824000_31.3.287.35
2016042200275824000_31.3.287.14
2016042200275824000_31.3.287.36
2016042200275824000_31.3.287.11
2016042200275824000_31.3.287.12
2016042200275824000_31.3.287.34
2016042200275824000_31.3.287.31
2016042200275824000_31.3.287.10
2016042200275824000_31.3.287.9
2016042200275824000_31.3.287.8
2016042200275824000_31.3.287.5
Schrader (2016042200275824000_31.3.287.41) 2000; 28
2016042200275824000_31.3.287.7
2016042200275824000_31.3.287.6
Hammond (2016042200275824000_31.3.287.33) 2008; 17(Suppl 1)
2016042200275824000_31.3.287.1
2016042200275824000_31.3.287.3
2016042200275824000_31.3.287.2
IARC (2016042200275824000_31.3.287.4) 2012; 100E
IARC (2016042200275824000_31.3.287.32) 2012; 100F
2016042200275824000_31.3.287.19
2016042200275824000_31.3.287.29
2016042200275824000_31.3.287.26
2016042200275824000_31.3.287.24
2016042200275824000_31.3.287.25
IARC (2016042200275824000_31.3.287.30) 2004; 83
2016042200275824000_31.3.287.44
2016042200275824000_31.3.287.23
2016042200275824000_31.3.287.45
2016042200275824000_31.3.287.20
2016042200275824000_31.3.287.42
2016042200275824000_31.3.287.21
2016042200275824000_31.3.287.43
National Toxicology Program (2016042200275824000_31.3.287.27) 2011; 12
2016042200275824000_31.3.287.40
EFSA (2016042200275824000_31.3.287.22) 2009; 1150
IARC (2016042200275824000_31.3.287.28) 2012; 100E
References_xml – volume: 100F
  start-page: 111
  year: 2012
  ident: 2016042200275824000_31.3.287.32
  article-title: Benzo[a]pyrene, a review of human carcinogens: chemical agents and related occupations
  publication-title: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
– ident: 2016042200275824000_31.3.287.20
  doi: 10.1093/toxsci/kfs012
– volume: 100E
  start-page: 43
  year: 2012
  ident: 2016042200275824000_31.3.287.4
  article-title: Tobacco smoking, a review of human carcinogens: personal habits and indoor combustions
  publication-title: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
– ident: 2016042200275824000_31.3.287.35
  doi: 10.1093/toxsci/kfp037
– ident: 2016042200275824000_31.3.287.44
  doi: 10.3109/10408444.2013.853726
– ident: 2016042200275824000_31.3.287.6
– ident: 2016042200275824000_31.3.287.9
  doi: 10.1016/j.fct.2003.08.020
– ident: 2016042200275824000_31.3.287.16
  doi: 10.1016/j.mrgentox.2014.10.008
– ident: 2016042200275824000_31.3.287.23
  doi: 10.1093/toxsci/kfn083
– ident: 2016042200275824000_31.3.287.7
  doi: 10.1016/j.mrrev.2004.02.001
– ident: 2016042200275824000_31.3.287.39
  doi: 10.1002/em.20159
– volume: 12
  start-page: iii-499
  year: 2011
  ident: 2016042200275824000_31.3.287.27
  article-title: NTP 12th Report on Carcinogens
  publication-title: Rep Carcinog
– ident: 2016042200275824000_31.3.287.37
  doi: 10.1007/978-1-62703-742-6_34
– ident: 2016042200275824000_31.3.287.29
  doi: 10.1021/jf070649o
– ident: 2016042200275824000_31.3.287.40
  doi: 10.1093/carcin/bgn002
– ident: 2016042200275824000_31.3.287.36
  doi: 10.1021/tx0600907
– ident: 2016042200275824000_31.3.287.1
– ident: 2016042200275824000_31.3.287.3
– ident: 2016042200275824000_31.3.287.26
  doi: 10.1016/S0278-6915(00)00164-2
– ident: 2016042200275824000_31.3.287.5
  doi: 10.1038/nrc1190
– ident: 2016042200275824000_31.3.287.15
  doi: 10.1002/em.21870
– ident: 2016042200275824000_31.3.287.25
  doi: 10.1016/S0278-6915(97)00063-X
– ident: 2016042200275824000_31.3.287.45
  doi: 10.1016/j.yrtph.2005.07.003
– ident: 2016042200275824000_31.3.287.11
  doi: 10.1016/j.mrgentox.2009.12.011
– ident: 2016042200275824000_31.3.287.10
  doi: 10.1093/mutage/geq083
– ident: 2016042200275824000_31.3.287.21
  doi: 10.1002/em.21825
– ident: 2016042200275824000_31.3.287.24
  doi: 10.1016/j.taap.2010.10.016
– ident: 2016042200275824000_31.3.287.38
  doi: 10.1002/em.21698
– ident: 2016042200275824000_31.3.287.18
  doi: 10.1002/em.21854
– volume: 83
  start-page: 1189
  year: 2004
  ident: 2016042200275824000_31.3.287.30
  article-title: Involuntary smoking, tobacco smoke and involuntary smoking
  publication-title: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
– ident: 2016042200275824000_31.3.287.31
– volume: 28
  start-page: 180
  year: 2000
  ident: 2016042200275824000_31.3.287.41
  article-title: Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in primary cultures of rat alveolar type II cells
  publication-title: Drug Metab. Dispos
  doi: 10.1016/S0090-9556(24)15126-4
– ident: 2016042200275824000_31.3.287.13
  doi: 10.1016/j.tox.2006.07.019
– ident: 2016042200275824000_31.3.287.34
  doi: 10.1073/pnas.87.1.51
– ident: 2016042200275824000_31.3.287.14
  doi: 10.1002/em.21727
– ident: 2016042200275824000_31.3.287.19
  doi: 10.1371/journal.pone.0064532
– volume: 17(Suppl 1)
  start-page: i24
  year: 2008
  ident: 2016042200275824000_31.3.287.33
  article-title: Constituents in tobacco and smoke emissions from Canadian cigarettes
  publication-title: Tob. Control
  doi: 10.1136/tc.2008.024778
– ident: 2016042200275824000_31.3.287.12
  doi: 10.1016/j.tox.2003.08.006
– ident: 2016042200275824000_31.3.287.2
– volume: 100E
  start-page: 213
  year: 2012
  ident: 2016042200275824000_31.3.287.28
  article-title: Second-hand tobacco smoke, a review of human carcinogens: personal habits and indoor combustions
  publication-title: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
– ident: 2016042200275824000_31.3.287.8
  doi: 10.1016/j.mrgentox.2007.09.006
– ident: 2016042200275824000_31.3.287.17
  doi: 10.1016/j.mrgentox.2014.09.011
– ident: 2016042200275824000_31.3.287.42
  doi: 10.1038/nrc1546
– ident: 2016042200275824000_31.3.287.43
  doi: 10.1016/j.taap.2009.03.026
– volume: 1150
  start-page: 1
  year: 2009
  ident: 2016042200275824000_31.3.287.22
  article-title: Guidance of the Scientific Committee on a request from EFSA on the use of the benchmark dose approach in risk assessment
  publication-title: EFSA J
SSID ssj0017260
Score 2.2722437
Snippet Quantifying health-related biological effects, like genotoxicity, could provide a way of distinguishing between tobacco products. In order to develop tools for...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 287
SubjectTerms Activation, Metabolic
Aminobiphenyl Compounds - metabolism
Aminobiphenyl Compounds - toxicity
Animals
Benzo(a)pyrene - metabolism
Benzo(a)pyrene - toxicity
Cadmium Chloride - toxicity
Carcinogens - toxicity
Cell Line, Tumor
DNA Damage
DNA, Neoplasm - drug effects
DNA, Neoplasm - metabolism
Lymphoma
Mice
Mutagenicity Tests
Mutagens - toxicity
Nitrosamines - metabolism
Nitrosamines - toxicity
Quinolines - metabolism
Quinolines - toxicity
Rats
Smoke - analysis
Title Quantitative analysis of the relative mutagenicity of five chemical constituents of tobacco smoke in the mouse lymphoma assay
URI https://www.ncbi.nlm.nih.gov/pubmed/26001754
https://www.proquest.com/docview/1783913209
https://www.proquest.com/docview/1805493127
https://pubmed.ncbi.nlm.nih.gov/PMC6419102
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA7jiuCLeHe8EUF8GbvbpplM51G8LcoKC7swbyVJ093iTru6rbCC_91zcmk7rivqSylN2tB-X09OkpPvEPIcvWwmiizSIjERL3gWScXgDKU-DJfz0kop7X0Su4f8w2q-mkzGUUtdq7b199_uK_kfVOEa4Iq7ZP8B2f6hcAHOAV84AsJw_CuM9ztZ201iGP4jR_IiNm7QhrlBwbprwWjUlfbRFyVe1EEoQDcuXMD4eBj8wbVuZmfr5rMJUZA4P2BmJ-cAfbOWM3C45cZy8J5rwpxVvYv-vrOTsKtKNl9C92jnXHEXyvEQ1D3sjnhT2eQD6P9qsFT9rDTu_ffpQ1xCgUr6GVg_W5GIITZw2zgLywWP0szlHA4m2HcE1XiE7uyp640v2HmngeW-H5wcmW-x00QaoX66trCjAj_4SHzo8PowxFB0hVxlMMpAM_lxf1iEWkC5l2WF9nZcazuuLRSR9ndvejQXhim_RtuO3JeDm-SGH3fQV45Et8jE1LfJNZeJ9PwO-TGmEg1Uok1JAX4aqETHVMJCpBINVKJjKtlbHZWopRKtavssSyUaqEQtle6Sw3dvD17vRj4zR6R5JtpISKkKFhdCFTEzOo2ZlIXmJimZgl8cXMJlKuSi1HCYl0tepCgTJ3WcZEqVpkjvka26qc0DQuNUMlaYlBnwFo3JZCYEyxjcXKo0maspeRm-bq69bD1mTznJXfhEmrtXzx0uU_Kir37q9Fouq_gsQJWDRcVlMlkb-AR5soBBAyoL_KlOBkOdZZqwxZTcd_D2zQVeTMliA_i-Aiq6b5bU1bFVdhc8AfedPbz0mY_I9eGveky22q-deQJecaueWu7-BOIpxFs
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitative+analysis+of+the+relative+mutagenicity+of+five+chemical+constituents+of+tobacco+smoke+in+the+mouse+lymphoma+assay&rft.jtitle=Mutagenesis&rft.au=Guo%2C+Xiaoqing&rft.au=Heflich%2C+Robert+H&rft.au=Dial%2C+Stacey+L&rft.au=Richter%2C+Patricia+A&rft.date=2016-05-01&rft.eissn=1464-3804&rft.volume=31&rft.issue=3&rft.spage=287&rft_id=info:doi/10.1093%2Fmutage%2Fgev039&rft_id=info%3Apmid%2F26001754&rft.externalDocID=26001754
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0267-8357&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0267-8357&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0267-8357&client=summon